Patents Assigned to Orthofix, Inc.
  • Patent number: 11045647
    Abstract: A system and method for PEMF tissue engineering enhances musculoskeletal tissue stimulation by monitoring treatment for compliance with treatment regimens. A PEMF device includes sensors that detect attributes indicating whether the PEMF device is in use. The PEMF device also includes communication devices that connect it with other devices. The data obtained from the sensors may be used to determine a level of compliance in use of the tissue engineering device with a prescribed treatment regimen for the patient. The data is transferred via a paired UE to a remote server. The remote server stores the data in a database and periodically generates compliance reports. The compliance reports are shared with subscribing access devices including the prescribing physician. The UE pairing with the PEMF device maintains a treatment calendar and dynamically modifies reminders based on current treatment status. The treatment regimen may be updated and sent to the PEMF device.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 29, 2021
    Assignee: ORTHOFIX INC.
    Inventors: James T. Ryaby, Mamak Monica Keramat, Lesley Allen Bowling, Bobby Don Harris, James Sterling Denton, Philip Hartley Garman, Jeffrey James Culhane, Jonelle Matilda Juricek
  • Patent number: 10653881
    Abstract: A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation. A tissue engineering device may include both low and high pulse frequency signal generation components that may alternatively drive one or more coils to generate PEMFs. These PEMFs may be applied to bone tissue, tendons, ligaments, and/or cartilage. A prescribed treatment regimen using the tissue engineering device may include a first period of time where a first pulse frequency is used in treatment that supports tissue proliferation followed by a second period of time where a second pulse frequency (less than the first pulse frequency) is used in treatment that supports tissue differentiation. A treatment regimen may also include, with the frequency characteristic, applying a slew rate to the pulse characteristics that is on the order of around 30 to 100 Tesla per second to drive tissue differentiation in a targeted manner.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: May 19, 2020
    Assignee: Orthofix, Inc.
    Inventors: James T. Ryaby, Erik Waldorff, Ronald Midura, Maciej Zborowski
  • Patent number: 10238867
    Abstract: A system and method for PEMF tissue engineering enhances musculoskeletal tissue stimulation by monitoring treatment for compliance with treatment regimens. A PEMF device includes sensors that detect attributes indicating whether the PEMF device is in use. The PEMF device also includes communication devices that connect it with other devices. The data obtained from the sensors may be used to determine a level of compliance in use of the tissue engineering device with a prescribed treatment regimen for the patient. The data is transferred via a paired UE to a remote server. The remote server stores the data in a database and periodically generates compliance reports. The compliance reports are shared with subscribing access devices including the prescribing physician. The UE pairing with the PEMF device maintains a treatment calendar and dynamically modifies reminders based on current treatment status. The treatment regimen may be updated and sent to the PEMF device.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: March 26, 2019
    Assignee: Orthofix Inc.
    Inventors: James T. Ryaby, Mamak Monica Keramat, Lesley Allen Bowling, Bobby Don Harris, James Sterling Denton, Philip Hartley Garman, Jeffrey James Culhane, Jonelle Matilda Juricek
  • Patent number: 6364824
    Abstract: A method and associated apparatus are presented for stimulating biological activity of cell receptors. The biological activity of cell receptors is stimulated by positioning a transmitter in proximity with the target cell receptors, generating an electromagnetic field, such that the flux of the electromagnetic field extends through the target cell receptors, and fluctuating the electromagnetic field at a predetermined rate of fluctuation. An associated apparatus is presented which stimulates biological activity of cell receptors. The apparatus comprises a field coil electrically connected to an alternating current source with a predetermined rate of fluctuation. The alternating current flows through the field coils, thereby generating an electromagnetic field with a predetermined rate of fluctuation.
    Type: Grant
    Filed: November 11, 1999
    Date of Patent: April 2, 2002
    Assignee: Orthofix, Inc.
    Inventor: Robert J. Fitzsimmons
  • Patent number: D859672
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: September 10, 2019
    Assignee: ORTHOFIX INC.
    Inventor: Steve Blake
  • Patent number: D860467
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: September 17, 2019
    Assignee: ORTHOFIX INC.
    Inventor: Steve Blake
  • Patent number: D861898
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: October 1, 2019
    Assignee: ORTHOFIX INC.
    Inventor: Steve Blake
  • Patent number: D861899
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: October 1, 2019
    Assignee: ORTHOFIX INC.
    Inventor: Steve Blake
  • Patent number: D861900
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: October 1, 2019
    Assignee: ORTHOFIX INC.
    Inventor: Steve Blake
  • Patent number: D871597
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: December 31, 2019
    Assignee: Orthofix Inc.
    Inventor: Steve Blake
  • Patent number: D904630
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: December 8, 2020
    Assignee: Orthofix Inc.
    Inventor: Steve Blake